• 제목/요약/키워드: Supportive Care

검색결과 404건 처리시간 0.025초

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

  • Kang, Seong Hee;Cho, Hyeki;Cho, Eun Ju;Lee, Jeong-Hoon;Yu, Su Jong;Kim, Yoon Jun;Yi, Nam-Joon;Lee, Kwang-Woong;Suh, Kyung-Suk;Yoon, Jung-Hwan
    • Journal of Korean Medical Science
    • /
    • 제33권45호
    • /
    • pp.283.1-283.10
    • /
    • 2018
  • Background: The role of sorafenib in patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been rarely studied. The aim of this study was to evaluate the efficacy of sorafenib in post-LT era. Methods: Consecutive patients with post-transplant HCC recurrence not eligible to resection or locoregional therapy were included. Patients receiving best supportive care (BSC) until 2007 were compared with those treated by sorafenib thereafter. Results: Of a total of 65 patients, 20 patients received BSC and 45 received sorafenib. Clinical characteristics were similar between two groups except that sorafenib group received tacrolimus and mammalian target-of-rapamycin inhibitors more frequently than BSC group. Treatment with sorafenib conferred a survival advantage as compared with BSC for survival after recurrence (median, 14.2 vs. 6.8 months; P = 0.01). In multivariate analyses, high serum ${\alpha}$-fetoprotein level, synchronous intrahepatic recurrence and distant metastasis at the time of recurrence, and BSC were independently associated with poorer survival after recurrence. Sorafenib treatment was associated with better survival after recurrence as compared with BSC (hazard ratio, 0.25; 95% confidence interval, 0.10-0.62; P = 0.002). In addition, sorafenib group showed tolerable toxicity in the post-transplant setting. Conclusion: Sorafenib may be beneficial in patients with post-transplant HCC recurrence.

Treating Viral Diarrhea in Children by Probiotic and Zinc Supplements

  • Ahmadipour, Shokoufeh;Mohsenzadeh, Azam;Alimadadi, Hosein;Salehnia, Mehdi;Fallahi, Arash
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제22권2호
    • /
    • pp.162-170
    • /
    • 2019
  • Purpose: The aim of this study was to analyze the effects of probiotics and zinc supplements on the mean duration and frequency of acute diarrhea in children aged 6 months to 2 years. Methods: In this clinical trial of infants aged between 6 months and 2 years, eligible patients were divided into 3 groups: Zinc Receiving Group (ZRG), Probiotic Receiving Group (PRG), and a control group receiving supportive care alone. The frequency of diarrhea was evaluated in the test groups during the first 24 hours and 48-72 hours, along with the duration of hospitalization and diarrhea persistence for 3-7 days. Results: Diarrhea persisted for until the third day of admission in 100% of the infants in PRG compared with only 76.1% in ZRG. The relative risk of diarrhea persistence in the PRG was 1.31 times more than in ZRG until the third day. Also, 80% of diarrhea cases in the PRG persisted until the fourth day of admission, compared with 47.8% in the ZRG group, and this value was significant. The relative incidence of diarrhea persistence in the PRG was 36.4 times greater than in the ZRG until the day 4. Also, the percentage of post-treatment complications was 35.5% in the PRG and 2.6% in the ZRG, which was significant. Conclusion: In our study, the effectiveness of zinc at a dose of 20 mg was higher than that of probiotics. The complications associated with zinc supplementation were lower than those of probiotics.

Treatment and clinical outcomes of patients relapsing after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome

  • Choi, Eun-Ji;Lee, Je-Hwan;Lee, Jung-Hee;Park, Han-Seung;Ko, Sun-Hye;Seol, Miee;Lee, Young-Shin;Kang, Young-Ah;Jeon, Mijin;Lee, Kyoo-Hyung
    • BLOOD RESEARCH
    • /
    • 제53권4호
    • /
    • pp.288-293
    • /
    • 2018
  • Background Although allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment option for myelodysplastic syndrome (MDS), a substantial number of patients experience relapse. We reviewed the clinical outcomes of patients with MDS who relapsed after allogeneic HCT. Methods Thirty patients who experienced relapse or progression after allogeneic HCT for MDS between July 2000 and May 2016 were included in this retrospective analysis. Results The median time from HCT to relapse was 6.6 (range, 0.9-136.3) months. Donor lymphocyte infusions (DLIs) were administered to four patients: one achieved complete remission (CR) and survived disease free, while three did not respond to DLI and died. Hypomethylating agents were administered to seven patients: one who had stable disease continuously received decitabine, while six died without response to treatment. Six patients received AML-like intensive chemotherapy, and three achieved CR: two underwent second HCT and one DLI. One patient receiving second HCT survived without disease, but the other two relapsed and died. Three, four, and eight patients who did not respond to intensive chemotherapy, low-dose cytarabine, and best supportive care, respectively, died. One patient who underwent second HCT following cytogenetic relapse survived disease free. Median overall survival after relapse was 4.4 months, and relapse within 6 months after HCT was associated with shorter survival. Conclusion Outcomes of MDS patients relapsing after allogeneic HCT were disappointing. Some patients could be saved using DLI or second HCT.

A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors

  • Kim, Hyojeong;Lee, Eun Mi
    • Brain Tumor Research and Treatment
    • /
    • 제6권2호
    • /
    • pp.54-59
    • /
    • 2018
  • Background Leptomeningeal metastasis (LM) is an uncommon, but devastating complication of advanced cancer and has no standard treatment. Herein, we analyzed the clinical characteristics and outcomes of patients with solid tumors who were diagnosed with LM. Methods Between January 2007 and December 2017, we retrospectively analyzed the medical records of patients with solid tumors who were diagnosed with LM. Results A total of 58 patients were enrolled in this study. The median age of patients was 51 years (range, 27-72 years), and 62.1% had a poor Eastern Cooperative Oncology Group (ECOG) performance status (PS) (>2). The common types of primary tumor were breast cancer (39.7%), gastric cancer (25.9%), and non-small cell lung cancer (20.7%). Forty-two patients (72.4%) were diagnosed with LM by MRI of the brain and/or spine and cerebrospinal fluid (CSF) analysis, 14 were diagnosed by CSF analysis alone, and 2 were diagnosed by MRI alone. Treatments for LM were performed in 53 patients (91.4%), and best supportive care was provided for 5 patients (8.6%). Intrathecal chemotherapy, radiotherapy, and systemic chemotherapy were administered in 43 (74.1%), 17 (29.3%), and 24 (41.4%) patients, respectively. The median overall survival of the entire cohort was 2.4 months (95% confidence interval, 1.0-3.7). In the analysis of prognostic factors for survival, a good ECOG PS (${\leq}2$), administration of systemic chemotherapy after LM diagnosis, and a prior history of brain radiation were associated with prolonged survival. Conclusion Although the prognosis of LM in patients with solid tumors is poor, systemic chemotherapy might improve survival in selected patients with a good PS.

Treatment Modality Based Survival in Gastric Carcinoma Patients with Stand-Alone Peritoneal Metastasis: a Case-Control Study

  • Jeong, Oh;Jung, Mi Ran;Kang, Ji Hoon
    • Journal of Gastric Cancer
    • /
    • 제21권2호
    • /
    • pp.122-131
    • /
    • 2021
  • Purpose: To date, there are no promising treatments for gastric carcinoma with peritoneal metastasis. Some researchers have suggested a survival benefit of gastrectomy in select patients. This study investigated the survival of gastric carcinoma patients with stand-alone peritoneal metastasis according to the type of treatment modality. Materials and Methods: We reviewed the data of 132 patients with gastric carcinoma and stand-alone peritoneal metastasis. We performed gastrectomy when the primary tumor was deemed resectable and systemic chemotherapy was administered. We analyzed patient survival according to the type of treatment, and the prognostic value of gastrectomy was evaluated in univariate and multivariate models. Results: Among all patients, 70 underwent gastrectomy plus chemotherapy, 20 underwent gastrectomy alone, 36 underwent chemotherapy alone, and 6 received supportive care. The median patient survival was 13 months. Patients who underwent gastrectomy had significantly longer survival than those who did not undergo gastrectomy (14 vs. 8 months, P<0.001). Patients who received chemotherapy showed significantly longer survival than those who did not (13 vs. 7 months, P=0.032). Patients who underwent gastrectomy plus chemotherapy showed better survival than those who underwent other treatments. In multivariate analysis, gastrectomy was found to be an independent prognostic factor (hazard ratio, 0.52; 95% confidence interval, 0.33-0.82) in addition to chemotherapy. Conclusions: Our study showed that patients who underwent gastrectomy plus chemotherapy had the best survival. Although the survival benefit of gastrectomy remains uncertain, it is a favorable prognostic indicator in patients with stand-alone peritoneal metastasis.

영유아기 자녀를 둔 어머니의 출산전후휴가 및 육아휴직제도 이용 경험 (Mothers' experiences using maternity and parental leave)

  • 손서희
    • 한국가족관계학회지
    • /
    • 제22권1호
    • /
    • pp.87-109
    • /
    • 2017
  • Objectives: While employed mothers' use of maternity and parental leave has increased, the contexts that facilitate or hinder mothers' leave policy use have been under examined. The purpose of this study was to explore mothers' experiences of using maternity and parental leave. Method: Twenty-two mothers with young child under age three participated in this study. Results: All 22 mothers used maternity leave and 12 mothers used parental leave. Three main themes were identified: different experiences of maternity leave, experiences of parental leave, and skepticism about the leave policy but with some hope that it will improve. Regarding the mothers' experiences of maternity leave, the mothers thought that maternity leave was easily accessible but some mothers still felt guilty for using maternity leave. They also prepared for their work gap before the leave to avoid harming their colleagues. Accessibility to parental leave varied according to the characteristics of the organizations (i.e., family-friendly organization culture, supportive supervisor) and family contexts (i.e., availability of child care from family members, financial issues). The mothers perceived that while parental leave helps working mothers coordinate their family and work life, it is not as accessible as maternity leave in Korea. They suggested extending the maternity leave duration and improving accessibility to parental leave. Conclusions: These findings suggest that policy support is warranted to help employed mothers with young children remain in the workforce. This study also has implications for supporting employed mothers' work and family life.

대학생의 COVID - 19로 인한 온라인 학업 경험 (Virtual Academic Experience of College Students Due to COVID-19)

  • 김영희
    • 한국산학기술학회논문지
    • /
    • 제21권12호
    • /
    • pp.278-290
    • /
    • 2020
  • 본 연구는 대학생의 COVID-19로 인한 온라인 학업 경험을 현상학적으로 이해하고, 그 내용을 밝히기 위해 수행되었다. 이를 위해 Colaizzi의 분석 방법에 따라 15명의 심층 면담 자료를 분석하였다. 그 결과 참여자들은 눈높이 학습 욕구와 불만족스러운 학업 요인들에의 짜증, 학업 만족도를 높이는 요인들에의 고마움,, 온라인 강의에서의 요인들과 외로운 싸움, 건강관리를 통한 조화 도모 등을 나타냈다. 이러한 결과를 통해 다음과 같은 결론을 도출하였다. 첫째, 학생들의 눈높이 학습이 가능하도록 수단을 마련해야 한다. 둘째, 전달력과 집중력을 높이기 위한 변화를 도모해야 한다. 셋째, 소통을 향한 교수의 노력 및 성실성과 열정은 수업에서 학생들을 감동시킨다. 넷째, 공감적이고 지지적인 수업 분위기를 조성하기 위한 교수-학습자 간의 협력이 필요하다. 다섯째, 코로나가 종식될 때까지 원격 교육의 원칙이 특별한 경우를 제외하고는 고수되어야 한다. 온라인 강의에서의 만족도를 높일 수 있는 구체적인 방법까지 제시한 본 연구 결과는 효과적인 온라인 수업 방향을 설정하기 위한 기초 자료로 활용될 수 있을 것이다.

Preemptive pyloroplasty for iatrogenic vagus nerve injury in intrahepatic cholangiocarcinoma patients undergoing extensive left-sided lymph node dissection: a retrospective observational study

  • Hwang, Shin;Jung, Dong-Hwan;Jwa, Eun-Kyoung;Kim, Yumi
    • Journal of Yeungnam Medical Science
    • /
    • 제39권3호
    • /
    • pp.235-243
    • /
    • 2022
  • Background: Intrahepatic cholangiocarcinoma (ICC) of the left liver often shows left-sided lymph node (LN) metastasis. If gastric lesser curvature is extensively dissected, it can induce an iatrogenic injury to the extragastric vagus nerve branches that control motility of the pyloric sphincter and lead to gastric stasis. To cope with such LN dissection-associated gastric stasis, we performed pyloroplasty preemptively. The objective of this study was to analyze our 20-year experience of preemptive pyloroplasty performed in 10 patients. Methods: We investigated clinical sequences of 10 patients with ICC who underwent preemptive pyloroplasty following left hepatectomy and extended left-sided LN dissection. Incidence of gastric stasis and oncological survival outcomes were analyzed. Results: All 10 patients were classified as stage IIIB due to T1-3N1M0 stage according to the 8th edition of American Joint Committee on Cancer staging system. The overall patient survival rate was 51.9% at 1 year, 25.9% at 2 years, and 0% at 3 years. Seven patients showed uneventful postoperative recovery after surgery. Two patients suffered from gastric stasis, which was successfully managed with supportive care. One patient suffered from overt gastric paresis, which was successfully managed with azithromycin administration for 1 month. Conclusion: We believe that preemptive pyloroplasty is an effective surgical option to prevent gastric stasis in patients undergoing extensive left-sided LN dissection. Azithromycin appears to be a potent prokinetic agent in gastroparesis.

Long-term outcomes after peri-implantitis treatment and their influencing factors: a retrospective study

  • Lee, Sung-Bae;Lee, Bo-Ah;Choi, Seong-Ho;Kim, Young-Taek
    • Journal of Periodontal and Implant Science
    • /
    • 제52권3호
    • /
    • pp.194-205
    • /
    • 2022
  • Purpose: This study aimed to determine the long-term outcomes after peri-implantitis treatment and the factors affecting these outcomes. Methods: This study included 92 implants in 45 patients who had been treated for peri-implantitis. Clinical data on the characteristics of patients and their implants were collected retrospectively. The change in the marginal bone level was calculated by comparing the baseline and the most recently obtained (≥3 years after treatment) radiographs. The primary outcome variable was progression of the disease after the treatment at the implant level, which was defined as further bone loss of >1.0 mm or implant removal. A 2-level binary logistic regression analysis was used to identify the effects of possible factors on the primary outcome. Results: The mean age of the patients was 58.7 years (range, 22-79 years). Progression of peri-implantitis was observed in 64.4% of patients and 63.0% of implants during an observation period of 6.4±2.7 years (mean±standard deviation). Multivariable regression analysis revealed that full compliance to recall visits (P=0.019), smoking (P=0.023), placement of 4 or more implants (P=0.022), and marginal bone loss ≥4 mm at baseline (P=0.027) significantly influenced the treatment outcome. Conclusions: The long-term results of peri-implantitis treatment can be improved by full compliance on the part of patients, whereas it is impaired by smoking, placement of multiple implants, and severe bone loss at baseline. Encouraging patients to stop smoking and to receive supportive care is recommended before treatment.

ADA Levels in Body Fluids as the Preferred Test to Rule Out Tuberculosis in Limited-resource Settings: Data from a Tertiary Care Hospital in Northern India

  • Rasool, Rafia;Rashid, Gowhar;Mir, Shafat Ahmad;Rather, Tahseen Bilal;Mudassar, Syed
    • 대한임상검사과학회지
    • /
    • 제54권3호
    • /
    • pp.167-172
    • /
    • 2022
  • In clinical practice, the diagnosis of tuberculosis (TB) continues to be a challenge. The goal of this study was to evaluate the reliability and impact of adenosine deaminase (ADA) enzyme testing as a biochemical marker in the continued management of suspected tuberculosis in a limited resource setting hospital. The retrospective data were collected from 2018 to 2021 and comprised the results of all ADA test assays done in the laboratory. All types of body fluids received for ADA testing were analyzed. Over the course of two years, 1461 samples for ADA assay testing were received. The average age of the study population was 56.69±11.7 years, with males accounting for the majority of the subjects (55.72%). Pleural fluid (N=817, 55.92%) was the most common type of sample received for the ADA assay. 114 (13.95%) of the 817 pleural fluid samples were found to be positive. A survey was conducted to obtain physician's response regarding reliability on ADA testing. 100% of them reported the supportive role of ADA levels in the workup of patients with suspected tuberculosis. In a limited resource setting, the ADA test, in conjunction with clinical and other laboratory findings, can help physicians to initiate early treatment in hospitals for the benefit of patients.